Press release

AMGEN PRESENTS NEW REPATHA® (EVOLOCUMAB) DATA AT AHA 2022

Very low LDL-C

articleAmgen Inc.November 7, 20224/company/amgen-inc/news/amgen-presents-new-repathar-evolocumab-data-at-aha-2022-2022-11-07
AMGEN PRESENTS NEW REPATHA® (EVOLOCUMAB) DATA AT AHA 2022

About this update from Amgen Inc.

[{"type":"text","content":"Very low LDL-C Levels","length":57,"tagName":"div"}]

More updates from Amgen Inc.